Stock Forecast Chart
Stock Price Prediction Summary
Forecast Score Based on 2 Weeks
Based on our forecast, the price of THCBF will - over the next 2 Weeks and hit - by . In that time frame, THCBF's share price is expected to range between - and -.
BearishAverageBullish| Date | Predicted Lower | Predicted | Predicted Upper | ||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
No Data | |||||||||||||||||||
THCBF shares remained flat 0 in Wednesday, September 9, 2026's trading session, starting and closing at a previous close of $0.00 to move at $0.00. The stock demonstrated notable intraday movement (see THCBF's key stats for a full breakdown), fluctuating between $0.00 and $0.02, a +2,350.00% trading range. While recent weeks have seen some volatility, THCBF has managed to secure a 0 no change over the past 2 weeks. The neutral price movement was accompanied by decreased trading volume, with approximately 500 shares changing hands, 10K fewer than the previous session. This amounted to $0.50 in total market activity.
Will THCBF Continue Its Trend?
According to analyst ratings and projections for THCBF, THC Biomed Intl Ltd. shares are anticipated to remain stable by -, potentially reaching - per share by January 1, 1970. Short-term technical indicators for THCBF currently suggest a bearish sentiment. This aligns with the stock's recent performance, as it has recorded 28 negative trading days within the past 30 sessions. Based on the THCBF stock forecast, now is not the best time to buy THCBF stock because its current trading price is - our predicted value, hinting at a possible . For deeper insights, view our sentiment analysis on THCBF covering social and institutional perspectives.
THCBF Technical Momentum: Overbought, Oversold, or Neutral?
An analysis of Relative Strength Index (RSI) indicators provides insight into THCBF's momentum. Short-term RSIs (9, 14, and 20-day figures ranging from 51.29% to 52.94%) suggest the stock is in a neutral to slightly bearish momentum phase. The 50-day RSI, at 50.52%, suggests a neutral medium-term outlook. Additionally, the 100-day RSI, at 49.83%, maintains a neutral outlook for the long term. Insights into THCBF's shareholder base show how institutional investors are positioning themselves during these momentum shifts

